ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

0RQE Idorsia Ltd

1,9775
0,00 (0,00%)
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Idorsia Ltd 0RQE London Ordinary Share
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 1,9775 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,9775
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202418:00UKREGIdorsia increases the consent fee in connection with the..
01.5.202418:00UKREGIdorsia increases the consent fee in connection with the..
26.4.202407:00UKREGJERAYGO (aprocitentan) recommended for approval in Europe..
26.4.202407:00UKREGJERAYGO (aprocitentan) recommended for approval in Europe..
23.4.202407:00UKREGIdorsia publishes an invitation to a bondholder meeting
23.4.202407:00UKREGIdorsia publishes an invitation to a bondholder meeting
17.4.202407:00UKREGIdorsia publishes a Financial Status required for an..
17.4.202407:00UKREGIdorsia publishes a Financial Status required for an..
11.4.202407:00UKREGIdorsia takes steps to address short-term liquidity needs
11.4.202407:00UKREGIdorsia takes steps to address short-term liquidity needs
22.3.202407:00UKREGIdorsia thanks Guy Braunstein for his years of service as he..
22.3.202407:00UKREGIdorsia thanks Guy Braunstein for his years of service as he..
20.3.202407:00UKREGUS FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) –..
20.3.202407:00UKREGUS FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) –..
18.3.202407:00UKREGIdorsia and Viatris successfully close the transaction for..
18.3.202407:00UKREGIdorsia and Viatris successfully close the transaction for..
28.2.202407:00UKREGIdorsia and Viatris enter into a significant global research..
28.2.202407:00UKREGIdorsia and Viatris enter into a significant global research..
10.1.202407:00GLOBEIdorsia presents at the J.P. Morgan Healthcare Conference –..
03.11.202322:30GLOBENew Phase 3 data with aprocitentan for patients with..
24.10.202307:00GLOBEIdorsia announces financial results for the first nine..
23.10.202307:00GLOBEIdorsia is committed to further the science of sleep with a..
17.10.202317:45GLOBEInvitation to Idorsia's Nine-Month 2023 Financial Reporting..
06.9.202307:00GLOBEIdorsia reacquires the world-wide rights to aprocitentan
25.7.202307:00GLOBEIdorsia announces financial results for the first half 2023..
21.7.202307:00GLOBEIdorsia announces a cost reduction initiative to be..
20.7.202308:30GLOBEIdorsia sells its Asia Pacific (ex-China) operations –..
18.7.202317:45GLOBEInvitation to Idorsia's HY 2023 Financial Results webcast..
10.7.202307:00GLOBEIdorsia announces its insomnia medication, QUVIVIQ..
26.6.202317:45GLOBENew Phase 3 data with aprocitentan for patients with..
23.6.202317:45GLOBENew Phase 3 data with aprocitentan to be presented at the..
20.6.202307:00GLOBEIdorsia has secured bridge financing in the amount of CHF..
12.6.202307:00GLOBEIdorsia launches QUVIVIQ (daridorexant) in Switzerland – a..
06.6.202307:00GLOBEIdorsia has entered into exclusive negotiations with regard..
30.5.202307:00GLOBEIdorsia announces a change to commercial leadership
04.5.202311:16GLOBEIdorsia holds its Annual General Meeting of Shareholders
03.5.202307:00GLOBEHealth Canada approves QUVIVIQ (daridorexant) for the..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock